1) Strategy & Leadership - IDEX is focused on growth strategies in targeted advantaged markets, leveraging the 8020 framework to enhance execution and profitability. - The company is committed to disciplined capital deployment, balancing organic investments, tuck-in acquisitions, and shareholder returns. - IDEX repurchased $76 million of shares in Q1 2026 and plans to maintain this pace throughout the year.

2) Financial & Segment Results - Q1 2026 results showed organic sales growth of 5% and an adjusted EBITDA margin of 26%, reflecting a 50 basis point YoY expansion. - Orders grew 10% organically, with Health & Science Technologies (HST) segment orders up 17% and Fluid & Metering Technologies (FMT) orders up 9%. - HST revenue grew 11% organically, driven by strong demand in semiconductor, data center, and space and defense markets.

3) Problems / Headwinds - The FSDP segment faced a 4% decline in organic orders, attributed to tough comps and project volume declines in North America and Asia. - The company noted geopolitical uncertainties impacting visibility in FMT and FSDP segments, leading to a conservative outlook for these areas.

4) Operational or Product Plans - IDEX is enhancing its capabilities in the space and defense markets, focusing on critical components for high-value applications. - The company is actively pursuing bolt-on acquisitions to strengthen its market position and expand its portfolio in high-growth areas. - IDEX is also addressing margin pressures in HST by improving the performance of recently acquired businesses and focusing on high-value applications.

5) Guidance & Outlook / Investor Angle - IDEX raised its full-year 2026 organic growth guidance to 3%-4%, up from the previous 1%-2% forecast, reflecting strong order activity and backlog in HST. - Adjusted EPS guidance for 2026 was increased by $0.20 to a range of $8.35 to $8.55, indicating mid- to high single-digit growth YoY. - The company expects continued strong demand in its advantaged markets, with a positive outlook for the balance of 2026 and beyond.

Bottom line: IDEX's strong Q1 performance, driven by robust growth in HST and disciplined capital management, positions the company well for continued success in 2026, despite some headwinds in FMT and FSDP segments. The raised guidance reflects confidence in the company's strategic focus on high-value markets and operational excellence.